Weigh VTE Prevention Strategies in COVID-19

August 2020

Clinicians are scrambling to optimize venous thromboembolism (VTE) prophylaxis for hospitalized patients with COVID-19.

Data suggest these patients have a higher VTE risk than other hospitalized patients. Plus D-dimer and other markers are often elevated in COVID-19...especially in severe cases.

But there’s little evidence about optimal VTE prophylaxis in patients with COVID-19. Rely on a practical approach.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Infectious Diseases Consider Steroids for Some Hospitalized COVID-19 Patients
Influenza Prepare for More Demand for Flu Vaccines in 2020-21
Bites & Stings Stick With a Simple Approach for Bug Bites and Stings
Pediatrics Use the “KIDs List” to Identify Risky Meds in Children
Insulin Compare Lyumjev and Semglee to Other Insulins
Wound Care Ensure Patients With a Wound Are Protected Against Tetanus
Fungal Infections Set Expectations About Treating Toenail Fungus
Gastroenterology Address Med Concerns for Patients With Dysphagia
Women's Health Be Prepared for Questions About Menstrual Cups
Venous Thromboembolism Weigh VTE Prevention Strategies in COVID-19
Antimicrobial Stewardship Focus on Antimicrobial Stewardship During Care Transitions
Emergency Medicine Advise on Safe Med Use for Rapid Sequence Intubation

Weigh VTE Prevention Strategies in COVID-19

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Table of Contents